Mamoru Hasegawa

This inventor holds 37 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Gene Therapy. Top assignees: Dna Vec Research Inc., Id Pharma Co., Ltd., Dnavec Corporation. Active years: 2001-2021.

USPTO Granted Patents = 37 (Patent Applications = 11)

% Patents Active = 56.8

CIPO Patents = 3

EPO Patents = 12 (Patent Applications = 9)

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 144(Granted Patents)

Location History:

Ibaraki, JP (2001 - 2021)
Tsukuba, JP (2002 - 2021)

Company Filing History:

27 out of 31

Dna Vec Research Inc.

Japan, as Represented by the Director-General of National Institute of Infectious Disease

National Center for Global Health and Medicine

patents

7. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2021

Loading Chart...

Areas of Expertise:

Gene Therapy

Pluripotent Stem Cells

Viral Vectors

Reprogrammed Cells

RNA Virus

Dendritic Cells

AIDS Vaccines

Therapeutic Agents

Gene Transfer

Hybrid Promoters

Cancer Treatment

Electroporation

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11136594 - Method for production of reprogrammed cell using chromosomally unintegrated virus vector (2021-10-05),

2. 10975358 - Method for improving efficiency of inducing pluripotent stem cell (2021-04-13),

3. 10017784 - Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein (2018-07-10),

4. 9695445 - Method for production of reprogrammed cell using chromosomally unintegrated virus vector (2017-07-04),

5. 9492485 - Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor (2016-11-15),

6. 9447432 - Method for producing induced pluripotent stem cells (2016-09-20),

7. 9127256 - Method for production of reprogrammed cell using chromosomally unintegrated virus vector (2015-09-08),

8. 9090909 - Composition for inducing pluripotent stem cell, and use thereof (2015-07-28),

9. 8889118 - Anticancer agent containing dendritic cell having RNA virus transferred thereinto (2014-11-18),

10. 8741650 - Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter (2014-06-03),

11. 8283163 - Method for production of dendritic cell (2012-10-09),

12. 8278284 - Therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that use SIV-PEDF vectors (2012-10-02),

13. 8217019 - AIDS virus vaccines using Sendai virus vector (2012-07-10),

14. 8211868 - Paramyxovirus vector encoding angiogenesis gene and use thereof (2012-07-03),

15. 7709621 - Vectors with modified protease-dependent tropism (2010-05-04),

Title: The Innovative Journey of Mamoru Hasegawa

Introduction: Mamoru Hasegawa is a renowned inventor hailing from Ibaraki, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mamoru Hasegawa's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge medical devices for non-invasive diagnostics.

Career Highlights: With a career spanning over two decades, Mamoru Hasegawa has worked with leading research institutions and tech companies to develop revolutionary solutions in the areas of robotics, nanotechnology, and renewable energy.

Collaborations: Throughout his career, Mamoru Hasegawa has collaborated with top universities and multinational corporations to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Mamoru Hasegawa's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor in the global landscape of inventions and patents.